What is the recommended dose of Keflex (Cephalexin) for treating beta-strep (Group B streptococcus) urinary tract infection (UTI) in the first trimester of pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Keflex (Cephalexin) Dosing for Group B Streptococcus UTI in First Trimester Pregnancy

For pregnant women with Group B Streptococcus (GBS) urinary tract infection in the first trimester, the recommended dosage of Keflex (cephalexin) is 500 mg orally every 6 hours for 7-10 days. 1

Rationale for Treatment

GBS in urine during pregnancy requires immediate attention because:

  • Any amount of GBS in urine during pregnancy indicates heavy colonization
  • Treatment is necessary both for the current infection and to prevent complications
  • Untreated GBS UTI increases risks of premature rupture of membranes and preterm labor

Antibiotic Selection

Cephalexin (Keflex) is an appropriate first-line choice for GBS UTI in pregnancy for several reasons:

  • First-generation cephalosporins are effective against GBS
  • Cephalexin reaches high bactericidal concentrations in the urinary tract 2
  • It has an established safety profile in pregnancy
  • It demonstrates minimal induction of resistance in the vaginal flora 3

Treatment Duration

  • For uncomplicated GBS UTI: 7-10 days of treatment 1
  • For complicated UTI or pyelonephritis: 10-14 days of treatment 1
  • Treatment should continue for at least 48-72 hours after symptom resolution 1

Alternative Options

If penicillin allergy is present (without anaphylaxis risk):

  • Cefazolin: 2 g IV initial dose, then 1 g IV every 8 hours 1

If high risk of anaphylaxis:

  • Clindamycin: 900 mg IV every 8 hours (only if susceptibility testing confirms sensitivity) 1
  • Vancomycin: 1 g IV every 12 hours (for clindamycin-resistant strains) 1

Follow-up Recommendations

  1. Obtain a urine culture after completing treatment to confirm eradication 1
  2. Intrapartum prophylaxis will still be required during labor regardless of successful treatment earlier in pregnancy 1
  3. No need to re-screen with vaginal-rectal cultures at 35-37 weeks for women with GBS bacteriuria during pregnancy 1

Important Clinical Considerations

  • GBS in urine during pregnancy is significant at any colony count and always requires treatment 1
  • Nitrofurantoin may be effective for uncomplicated lower UTIs but is not preferred for GBS 1
  • Fluoroquinolones should be avoided during pregnancy due to potential adverse effects 1
  • Tetracyclines are contraindicated in pregnancy 1

Pitfalls to Avoid

  • Failing to treat GBS bacteriuria during pregnancy, even if asymptomatic
  • Using inadequate treatment duration (less than 7 days)
  • Not obtaining follow-up urine culture to confirm eradication
  • Forgetting that intrapartum prophylaxis is still required during labor despite previous treatment
  • Using antibiotics with poor urinary concentration or inadequate GBS coverage

By following these guidelines, clinicians can effectively manage GBS UTI in first trimester pregnancy while minimizing risks to both mother and fetus.

References

Guideline

Management of Group B Streptococcus Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cephalexin in the therapy of infections of the urinary tract.

Postgraduate medical journal, 1983

Research

Effective prophylaxis for recurrent urinary tract infections during pregnancy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.